Policy / Regulatory

China’s NAFR Enhances Tax Benefits for Private Health Insurance Purchases

CompanyDeals

Jacobio Pharma Secures RMB 150 Million Investment to Advance Pipeline Programs

CompanyMedical Device

Genesis MedTech Secures Chinese Market Approval for ArtiSential Laparoscopic Surgical Device

CompanyDrug

Shanghai Fosun Pharmaceutical Submits Daxibotulinumtoxin A (RT002) for NMPA Approval

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for SHR-1703 Clinical Study

CompanyDeals

C-Mer Eye Care Holdings Ltd Partners with Hong Kong Ophthalmologist for Novel Drug Development

CompanyDeals

ChengDu ShengNuo Biotechnology Aims to Raise RMB 160 Million for Peptide Drug CDMO Expansion

CompanyMedical Device

Peijia Medical Receives NMPA Approval for DCwire Micro Guide Wire Device in China

CompanyDeals

Chime Biologics, Leads Biolabs, and BeiGene Form Strategic Partnership for LAG-3 mAb LBL-007

CompanyDeals

Sirnaomics Ltd Partners with Edirna Inc. to Advance RNA Editing Therapy

Policy / Regulatory

CDE Launches Trial Procedures for Adding Pediatric Information to Drug Inserts

CompanyDeals

Sino Biopharmaceutical’s F-star Therapeutics Inks Third Licensing Deal with Takeda for Immunotherapies